• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

考虑脆弱性模型的具有隐藏失效原因的竞争风险数据的纵向生物标志物识别问题。

An issue of identifying longitudinal biomarkers for competing risks data with masked causes of failure considering frailties model.

机构信息

KF Statistical Consulting Company.

出版信息

Stat Methods Med Res. 2020 Feb;29(2):603-616. doi: 10.1177/0962280219842352. Epub 2019 Apr 16.

DOI:10.1177/0962280219842352
PMID:30991892
Abstract

In this paper, we consider joint modeling of repeated measurements and competing risks failure time data to allow for more than one distinct failure type in the survival endpoint. Hence, we can fit a cause-specific hazards submodel to allow for competing risks, with a separate latent association between longitudinal measurements and each cause of failure. We also consider the possible masked causes of failure in joint modeling of repeated measurements and competing risks failure time data. We also derive a score test to identify longitudinal biomarkers or surrogates for a time-to-event outcome in competing risks data which contain masked causes of failure. With a carefully chosen definition of complete data, the maximum likelihood estimation of the cause-specific hazard functions and of the masking probabilities is performed via an expectation maximization algorithm. The simulations are used to explore how the number of individuals, the number of time points per individual, and the functional form of the random effects from the longitudinal biomarkers considering heterogeneous baseline hazards in individuals influence the power to detect the association of a longitudinal biomarker and the survival time.

摘要

在本文中,我们考虑联合建模重复测量和竞争风险失效时间数据,以允许生存终点有多种不同的失效类型。因此,我们可以拟合一个特定原因的危险子模型,以允许竞争风险,并允许纵向测量与每种失效原因之间存在单独的潜在关联。我们还考虑了在重复测量和竞争风险失效时间数据的联合建模中可能存在的失效原因的隐蔽性。我们还推导出了一个得分检验,用于识别竞争风险数据中存在隐蔽失效原因的时间事件结果的纵向生物标志物或替代物。通过仔细选择完整数据的定义,通过期望最大化算法对特定原因的危险函数和掩蔽概率进行最大似然估计。模拟用于探索在个体的基线危险异质性下,个体的数量、每个个体的时间点数量以及考虑纵向生物标志物的随机效应的函数形式如何影响检测纵向生物标志物与生存时间关联的能力。

相似文献

1
An issue of identifying longitudinal biomarkers for competing risks data with masked causes of failure considering frailties model.考虑脆弱性模型的具有隐藏失效原因的竞争风险数据的纵向生物标志物识别问题。
Stat Methods Med Res. 2020 Feb;29(2):603-616. doi: 10.1177/0962280219842352. Epub 2019 Apr 16.
2
A joint model for longitudinal measurements and survival data in the presence of multiple failure types.存在多种失效类型时纵向测量与生存数据的联合模型。
Biometrics. 2008 Sep;64(3):762-771. doi: 10.1111/j.1541-0420.2007.00952.x. Epub 2007 Dec 20.
3
Robust joint modeling of longitudinal measurements and competing risks failure time data.纵向测量与竞争风险失效时间数据的稳健联合建模。
Biom J. 2009 Feb;51(1):19-30. doi: 10.1002/bimj.200810491.
4
Joint modeling of multivariate longitudinal data and the dropout process in a competing risk setting: application to ICU data.在竞争风险环境下对多元纵向数据和缺失数据过程进行联合建模:在 ICU 数据中的应用。
BMC Med Res Methodol. 2010 Jul 29;10:69. doi: 10.1186/1471-2288-10-69.
5
An approach to joint analysis of longitudinal measurements and competing risks failure time data.一种纵向测量与竞争风险失效时间数据联合分析的方法。
Stat Med. 2007 Jun 30;26(14):2813-35. doi: 10.1002/sim.2749.
6
Joint modeling of longitudinal ordinal data and competing risks survival times and analysis of the NINDS rt-PA stroke trial.纵向有序数据和竞争风险生存时间的联合建模及 NINDS rt-PA 中风试验分析。
Stat Med. 2010 Feb 28;29(5):546-57. doi: 10.1002/sim.3798.
7
New C-indices for assessing importance of longitudinal biomarkers in fitting competing risks survival data in the presence of partially masked causes.用于评估纵向生物标志物在存在部分掩盖病因的情况下拟合竞争风险生存数据时重要性的新C指数。
Stat Med. 2023 Apr 30;42(9):1308-1322. doi: 10.1002/sim.9671. Epub 2023 Jan 25.
8
A two-stage approach for joint modeling of longitudinal measurements and competing risks data.两阶段方法用于纵向测量和竞争风险数据的联合建模。
J Biopharm Stat. 2021 Jul 4;31(4):448-468. doi: 10.1080/10543406.2021.1918142. Epub 2021 Apr 27.
9
Investigating hospital heterogeneity with a competing risks frailty model.应用竞争风险脆弱模型研究医院异质性。
Stat Med. 2019 Jan 30;38(2):269-288. doi: 10.1002/sim.8002. Epub 2018 Oct 18.
10
Extending the code in the open-source saemix package to fit joint models of longitudinal and time-to-event data.将开源 saemix 包中的代码扩展以适应纵向和生存时间数据的联合模型。
Comput Methods Programs Biomed. 2024 Apr;247:108095. doi: 10.1016/j.cmpb.2024.108095. Epub 2024 Feb 23.